BDTX — Black Diamond Therapeutics Inc · $95.7M cap

Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.

Latest reported BDTX revenue for 2026-06-30 was $0. Net income was -$18.9M. BDTX currently screens at market cap $95.7M.

Use this BDTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BDTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BDTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Black Diamond Therapeutics Inc even when a live quote feed is slow.

Black Diamond Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full BDTX income, balance, and cash tables.

  • Revenue$70.0M
  • Net Income$22.4M
  • Total Assets$143.0M
  • Total Debt$0
  • Free Cash Flow$0

BDTX recent filings